All Stories

  1. Recent advances in understanding neuropathic pain: glia, sex differences, and epigenetics
  2. Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides
  3. Leukocyte opioid receptors mediate analgesia via Ca2+-regulated release of opioid peptides
  4. Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain
  5. Opioids and TRPV1 in the peripheral control of neuropathic pain – Defining a target site in the injured nerve
  6. Immunohistochemical Analysis of Opioid Receptors in Peripheral Tissues
  7. Electrophysiological Patch Clamp Assay to Monitor the Action of Opioid Receptors
  8. Analysis of Potassium and Calcium Imaging to Assay the Function of Opioid Receptors
  9. Skin–Nerve Preparation to Assay the Function of Opioid Receptors in Peripheral Endings of Sensory Neurons
  10. Peripheral Neuroimmune Interactions and Neuropathic Pain
  11. μ-Opioid Receptor Antibody Reveals Tissue-Dependent Specific Staining and Increased Neuronal μ-Receptor Immunoreactivity at the Injured Nerve Trunk in Mice
  12. Endogene Opioide: Ihre Wirkung kann man deutlich verstärken - Nachgehakt bei Prof. Dr. Halina Machelska und Prof. Dr. Christoph Stein
  13. Stronger Antinociceptive Efficacy of Opioids at the Injured Nerve Trunk Than at Its Peripheral Terminals in Neuropathic Pain
  14. Neuroimmune interactions after nerve injury and opioid-mediated pain control
  15. Impaired Nociception and Peripheral Opioid Antinociception in Mice Lacking Both Kinin B1 and B2 Receptors
  16. Cutaneous nociceptors lack sensitisation, but reveal μ-opioid receptor-mediated reduction in excitability to mechanical stimulation in neuropathy
  17. Modulation of Peripheral Sensory Neurons by the Immune System: Implications for Pain Therapy
  18. Control of Neuropathic Pain by Immune Cells and Opioids
  19. Dual Peripheral Actions of Immune Cells in Neuropathic Pain
  20. Analgesic effects of immune cells in neuropathic pain
  21. Activation of opioid receptors in injured nerves is required for efficient analgesia in neuropathic pain
  22. T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury
  23. Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain – a biochemical and behavioral study
  24. 105 T CELL-DERIVED AND EXOGENOUS OPIOIDS ACTING AT PERIPHERAL OPIOID RECEPTORS CONTROL NEUROPATHIC PAIN
  25. 286 PAIN CONTROL BY PREVENTION OF OPIOID PEPTIDE DEGRADATION IN PERIPHERAL INFLAMED TISSUE
  26. Immune cell–derived opioids protect against neuropathic pain in mice
  27. Immune cell–derived opioids protect against neuropathic pain in mice
  28. Peripheral non-viral MIDGE vector-driven delivery of β-endorphin in inflammatory pain
  29. Immune cells-mediated opioid release controls inflammatory pain
  30. Immune System, Pain and Analgesia
  31. Targeting of opioid-producing leukocytes for pain control
  32. Relative contribution of peripheral versus central opioid receptors to antinociception
  33. 292 T LYMPHOCYTES CONTRIBUTE TO OPIOID PAIN CONTROL IN NEURITIS
  34. 279 LEUKOCYTE-DERIVED OPIOIDS PRODUCE PERIPHERAL ANTINOCICEPTION IN NEUROPATHIC PAIN
  35. 291 EXPRESSION OF PERIPHERAL OPIOID RECEPTORS AND PEPTIDES IN A NEUROPATHIC PAIN MODEL
  36. Immune-derived Opioids: Production and Function in Inflammatory Pain
  37. A stomatin-domain protein essential for touch sensation in the mouse
  38. 275 LEUKOCYTE-DERIVED OPIOIDS INHIBIT NEUROPATHIC PAIN BY ACTIVATING PERIPHERAL OPIOID RECEPTORS
  39. Leukocyte-Derived Opioid Peptides and Inhibition of Pain
  40. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells
  41. Tissue Monocytes/Macrophages in Inflammation
  42. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain
  43. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression
  44. Mobilization of Opioid-containing Polymorphonuclear Cells by Hematopoietic Growth Factors and Influence on Inflammatory Pain
  45. Breaking the pain barrier
  46. Attacking pain at its source: new perspectives on opioids
  47. Different mechanisms of intrinsic pain inhibition in early and late inflammation
  48. Peripheral Opioid Analgesia Neuroimmune Interactions and Therapeutic Implications
  49. Peripheral analgesic and anti-inflammatory effects of opioids — neuro-immune crosstalk
  50. Immune Mechanisms in Pain Control
  51. Immune Mechanisms in Pain Control
  52. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain
  53. Peripheral analgesic and antiinflammatory effects of opioids
  54. Opioid Peptide–expressing Leukocytes
  55. Analgesic and Antiinflammatory Effects of Two Novel κ-Opioid Peptides
  56. Why is morphine not the ultimate analgesic and what can be done to improve it?
  57. Room B, 10/16/2000 2: 00 PM - 4: 00 PM (PS) Quantitative PCR of Opioid Peptide mRNAs Correlates with Stress-Induced Analgesia
  58. Room B, 10/16/2000 2: 00 PM - 4: 00 PM (PS) Granulocytes Mediate Endogenous Analgesia in Early Inflammatory Pain
  59. Co-expression of β-endorphin with adhesion molecules in a model of inflammatory pain
  60. Pain Control by Immune-Derived Opioids
  61. Pain control and the immune system
  62. Selectins promote pain control
  63. Antinociception after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitric oxide
  64. Pain control in inflammation governed by selectins
  65. Peripheral nociceptive integration
  66. Effects of pentylenetetrazol kindling on glutamate receptor genes expression in the rat hippocampus
  67. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord
  68. Effects of pilocarpine and kainate-induced seizures on N-methyl-d-aspartate receptor gene expression in the rat hippocampus
  69. Nitric oxide synthase inhibitor l-name prevents amphetamine-induced prodynorphin gene expression in the rat
  70. Intracerebroventricular galanin and N-terminal galanin fragment enhance the morphine-induced analgesia in the rat
  71. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats
  72. Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse
  73. Modulation of morphine and cocaine effects by inhibition of nitric oxide synthase
  74. The role of the nitric oxide pathway in the morphine- and cocaine-induced behavioral sensitization and proenkephalin gene expression
  75. Involvement of the nitric oxide pathway in nociceptive processes in the central nervous system in rats
  76. L-Nitroarginine methyl ester attenuates the development of morphine tolerance and dependence in mice
  77. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice
  78. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord
  79. Local burn injury profoundly enhances endogenous opioid systems activity in rats
  80. Faculty of 1000 evaluation for Case Report: Neuropathic pain in a patient with congenital insensitivity to pain.
  81. Faculty of 1000 evaluation for Case Report: Neuropathic pain in a patient with congenital insensitivity to pain
  82. Faculty of 1000 evaluation for Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain.
  83. Faculty of 1000 evaluation for Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain.
  84. Faculty of 1000 evaluation for TMEM16F Regulates Spinal Microglial Function in Neuropathic Pain States.
  85. Faculty of 1000 evaluation for Differential methylation of the TRPA1 promoter in pain sensitivity.
  86. Faculty of 1000 evaluation for Persistent Alterations in Microglial Enhancers in a Model of Chronic Pain.
  87. Faculty of 1000 evaluation for Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis.
  88. Faculty of 1000 evaluation for EULAR revised recommendations for the management of fibromyalgia.
  89. Faculty of 1000 evaluation for An industry perspective on the role and utility of animal models of pain in drug discovery.
  90. Faculty of 1000 evaluation for Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.
  91. Faculty of 1000 evaluation for Dorsal Horn Parvalbumin Neurons Are Gate-Keepers of Touch-Evoked Pain after Nerve Injury.
  92. Faculty of 1000 evaluation for Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats.
  93. Faculty of 1000 evaluation for Oligodendrocyte ablation triggers central pain independently of innate or adaptive immune responses in mice.
  94. Faculty of 1000 evaluation for Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.
  95. Faculty of 1000 evaluation for Bone marrow-derived cells in the population of spinal microglia after peripheral nerve injury.
  96. Faculty of 1000 evaluation for G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.
  97. Faculty of 1000 evaluation for Promoted Interaction of Nuclear Factor-κB With Demethylated Purinergic P2X3 Receptor Gene Contributes to Neuropathic Pain in Rats With Diabetes.
  98. Faculty of 1000 evaluation for Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells.
  99. Faculty of 1000 evaluation for Correlation Between DNA Methylation of TRPA1 and Chronic Pain States in Human Whole Blood Cells.
  100. Faculty of 1000 evaluation for Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of μ-Opioid Receptors in Primary Sensory Neurons.
  101. Faculty of 1000 evaluation for Suppression of Peripheral Pain by Blockade of Voltage-Gated Calcium 2.2 Channels in Nociceptors Induces RANKL and Impairs Recovery From Inflammatory Arthritis in a Mouse Model.
  102. Faculty of 1000 evaluation for Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial.